This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Sara Glashofer
Associate Director
Contact
SaraGlashofer@westat.comOverview
Sara Glashofer is an Associate Director for Public Health. An epidemiologist and project director with 30+ years of experience in clinical research. Glashofer oversees a large portfolio of projects for the National Cancer Institute’s (NCI’s) Clinical Genetics Branch and Integrative Tumor Epidemiology Branch, including high-profile clinical and epidemiological studies that are making important contributions to the advancement of cancer genetics. Her experience includes protocol development and the design of data collection instruments and procedures for large- and small-scale studies.
Education
- MS, Health Policy and Management, Harvard University School of Public Health
- BA (cum laude), Psychology (with a minor in Health and Society), Barnard College at Columbia University
-
Journal Article
Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline results and costs of a cluster-randomized trialAmerican Journal of Ophthalmology
2023
L.A. Hark, J.D. Horowitz, P. Gorroochurn, L. Park, Q. Wang, D.F. Diamond, N. Harizman, J.D. Auran, S.C. Maruri, D.R. Henriquez, J. Carrion, R.S.M. Muhire, Y.S. Kresch, L.T. Pizzi, E. Jutkowitz, Saloni Sapru, T. Sharma, C.G. De Moraes, D.S. Friedman, J.M. Liebmann, G.A. C
-
Journal Article
Cost-effectiveness of individual placement and support compared to transitional work program for veterans with post-traumatic stress disorderAdministration and Policy in Mental Health and Mental Health Services Research
2022
K.T. Stroupe, N. Jordan, J. Richman, G.R. Bond, T.K. Pogoda, L. Cao, S.G. Kertesz, T.C. Kyriakides, L.L. Davis
SOURCE -
Journal Article
Evaluation of an employment intervention for veterans transitioning from the military: A randomized controlled trialJournal of Nervous and Mental Disease
2022
G.R. Bond, M. Al-Abdulmunem, D.R. Ressler, Robert Drake, L.L. Davis, T. Meyer, D.M. Gade, B.C. Frueh, R.B. Dickman
SOURCE